Product Information
FAMOTIDINE 40 MG/5 ML SUSP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.2803 per ML under NDC 00832604515. Its NADAC has been published 78 times since Sep 18, 2024.
FDA first approved this application on Jun 16, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Famotidine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/5mL
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832604515
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
3/19/2025
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA217655FDA Approved
6/16/2023
TE Code
AB
On Market Since
6/16/2023
Pharmacological Classes
Price Statistics
The NADAC for FAMOTIDINE 40 MG/5 ML SUSP has been published 78 times since Sep 18, 2024, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2803 per ML |
|---|---|
| All-time high | $0.2803 (Mar 11, 2026) |
| All-time low | $0.2709 (Sep 18, 2024) |
| 52-week high | $0.2803 |
| 52-week low | $0.2803 |
| Median price | $0.2803 |
| Average price | $0.2797 |
| Largest weekly change | +3.5% (Oct 23, 2024) |
| Weeks tracked | 78 |
| Tracking since | Sep 18, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+3.5%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FAMOTIDINE 40 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FAMOTIDINE 40 MG/5 ML SUSP, manufactured by Upsher-Smith Laboratories LLC, is $0.2803 per ML (NDC 00832604515), effective Mar 11, 2026.
How has the price of FAMOTIDINE 40 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has risen 3.5%. It has been tracked across 78 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for FAMOTIDINE 40 MG/5 ML SUSP?
Since Sep 18, 2024, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has ranged from a low of $0.2709 (Sep 18, 2024) to a high of $0.2803 (Mar 11, 2026), with a median of $0.2803 per ML.
Are there cheaper alternatives to FAMOTIDINE 40 MG/5 ML SUSP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 40 MG/5 ML SUSP, is $0.1311 per ML — about 53% below FAMOTIDINE 40 MG/5 ML SUSP.
Who manufactures FAMOTIDINE 40 MG/5 ML SUSP?
FAMOTIDINE 40 MG/5 ML SUSP (NDC 00832604515) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.